KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Short term Debt (2019 - 2025)

Historic Short term Debt for Castle Biosciences (CSTL) over the last 5 years, with Q2 2025 value amounting to $1.9 million.

  • Castle Biosciences' Short term Debt changed N/A to $1.9 million in Q2 2025 from the same period last year, while for Jun 2025 it was $1.9 million, marking a year-over-year change of. This contributed to the annual value of $278000.0 for FY2024, which is N/A changed from last year.
  • Castle Biosciences' Short term Debt amounted to $1.9 million in Q2 2025.
  • Castle Biosciences' 5-year Short term Debt high stood at $20.8 million for Q1 2022, and its period low was $278000.0 during Q4 2024.
  • Over the past 3 years, Castle Biosciences' median Short term Debt value was $1.5 million (recorded in 2025), while the average stood at $6.0 million.